Evidence map›Paper›PMID 32246204›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2020

Combined mGlu

Stephen G Nuara, Adjia Hamadjida, Cynthia Kwan, Dominique Bédard, Imane Frouni, Jim C Gourdon, Philippe Huot

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Positive allosteric mGluRNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  2. Article
  3. Additive effects of mGluRNaunyn-Schmiedeberg's archives of pharmacology · 2021
    Article
  4. Effect of the mGluJournal of neural transmission (Vienna, Austria : 1996) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Stephen G NuaraComparative Medicine and Animal Resource Centre, McGill University, Montreal, QC, Canada.
Adjia HamadjidaNeurodegenerative Disease Group, Montreal Neurological Institute, 3801 University St, Montreal, QC, H3A 2B4, Canada.
Cynthia KwanNeurodegenerative Disease Group, Montreal Neurological Institute, 3801 University St, Montreal, QC, H3A 2B4, Canada.
Dominique BédardNeurodegenerative Disease Group, Montreal Neurological Institute, 3801 University St, Montreal, QC, H3A 2B4, Canada.
Imane FrouniDépartement de Pharmacologie et Physiologie, Université de Montréal, Montreal, QC, Canada.
Jim C GourdonComparative Medicine and Animal Resource Centre, McGill University, Montreal, QC, Canada.
Philippe HuotNeurodegenerative Disease Group, Montreal Neurological Institute, 3801 University St, Montreal, QC, H3A 2B4, Canada. philippe.huot@mcgill.ca.
Montreal Neurological Institute and Hospital · CAMcGill University · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent studies performed in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset model of Parkinson's disease (PD), we have demonstrated that activation of the metabotropic glutamate 2 (mGlu

Indexed as

Dyskinesia, Drug-InducedPsychotic DisordersAnimalsAntiparkinson AgentsBehavior, AnimalCallithrixLevodopaAntiparkinson AgentsLevodopaDyskinesiaLY-354,740LY-487,379MPTP-lesioned marmosetParkinson’s diseasePsychosis

Identifiers

PMID32246204
OpenAlexW3014295300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.